Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DCL000905

Drug Information
NameONO-2506    
SynonymsUNII-F2628ZD0FO; Cereact; ONO-2506; Acidum arundicum [INN-Latin]; MK-0724; Acido arundico [INN-Spanish]; CID208925; Proglia; AC1L4LMD; 185517-21-9; AC1Q5RZ6; D06296; Acide arundique; AR-1A2718; ONO-2506PO; Acide arundique [INN-French]; 186692-44-4; Arocyte; CID9815462; Arundic acid [INN]; KST-1A2706; Arundic acid (JAN/INN); Ono2506; Arundic acid; Acidum arundicum; 21447-39-2; AR-1E5222; (2R)-2-Propyloctanoic acid; Acido arzndico; AC1LB7DT; AC1Q5QIF; 2-Propyloctanoic acid; CID552716    
CompanyOno Pharmaceuticals    
IndicationStrokePhase III completed    
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
CAS NumberCAS 185517-21-9
FormularC11H22O2    
PubChem Compound IDCID 208925.    
PubChem Substance IDSID 783758.    
ClinicalTrials.govNCT00229177;    
TargetProstaglandin G/H synthase 2 Inhibitor[1]
Ref 1Emerging disease-modifying therapies for the treatment of motor neuron disease/amyotropic lateral sclerosis. Expert Opin Emerg Drugs. 2007 May;12(2):229-52. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543